127 related articles for article (PubMed ID: 2128028)
1. Treatment of systemic sclerosis.
Medsger TA
Curr Opin Rheumatol; 1990 Dec; 2(6):956-9. PubMed ID: 2128028
[No Abstract] [Full Text] [Related]
2. Effects of immunomodulating therapy in systemic sclerosis.
van den Hoogen FH; Boerbooms AM; van de Putte LB
Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
[TBL] [Abstract][Full Text] [Related]
3. Treatment with interferon gamma enhances fibrinolysis in systemic sclerosis.
Gluszko P; Undas A; Kwasny B; Musiał J; Szczeklik A
Thromb Res; 1998 Aug; 91(4):203-7. PubMed ID: 9736424
[No Abstract] [Full Text] [Related]
4. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
Arnaudova P; Rashkov R; Tsanev R
J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
[No Abstract] [Full Text] [Related]
5. Low dose methotrexate treatment in systemic sclerosis.
van den Hoogen FH; Boerbooms AM; van de Putte LB; Rasker JJ; van Venrooij WJ
J Rheumatol; 1991 Nov; 18(11):1763-4. PubMed ID: 1787505
[No Abstract] [Full Text] [Related]
6. Toward rational treatment of scleroderma.
Freundlich B
Hosp Pract (Off Ed); 1993 Sep; 28(9A):8, 13-4. PubMed ID: 8408363
[No Abstract] [Full Text] [Related]
7. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis.
Low AH; Lee P
J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063
[No Abstract] [Full Text] [Related]
8. Effect of interferon-gamma on experimental scleroderma induced by bleomycin.
Yamamoto T; Takagawa S; Kuroda M; Nishioka K
Arch Dermatol Res; 2000 Jul; 292(7):362-5. PubMed ID: 10966061
[No Abstract] [Full Text] [Related]
9. [Systemic sclerosis: drugs and new therapeutic methods].
Skretkowicz K; Waszczykowska E; Dziankowska-Bartkowiak B
Pol Merkur Lekarski; 2003 Sep; 15(87):263-7. PubMed ID: 14679854
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.
Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO
Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment in scleroderma.
van den Hoogen FH; Boerbooms AM; van de Putte LB
Am J Med; 1989 Jul; 87(1):116-7. PubMed ID: 2741971
[No Abstract] [Full Text] [Related]
12. Therapeutic interventions in systemic sclerosis.
van den Hoogen FH
Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147
[No Abstract] [Full Text] [Related]
13. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
Tanahashi K; Sugiura K; Muro Y; Akiyama M
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
[No Abstract] [Full Text] [Related]
14. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
Lehman TJ
Arthritis Rheum; 2002 Mar; 46(3):845. PubMed ID: 11920427
[No Abstract] [Full Text] [Related]
16. Photochemotherapy and methotrexate used to treat generalized cutaneous scleroderma.
Ridge CA; Moktar A; Barry J; Murphy GM
J Eur Acad Dermatol Venereol; 2007 May; 21(5):692-3. PubMed ID: 17447992
[No Abstract] [Full Text] [Related]
17. Methotrexate shows marginal clinical efficiency in early scleroderma.
Varga J
Curr Rheumatol Rep; 2002 Apr; 4(2):97-8. PubMed ID: 11890873
[No Abstract] [Full Text] [Related]
18. [Scleroderma and Gougerot-Sjögren syndrome. Effect of methotrexate therapy].
Welin J; Grolleau JY; Barrière H
Sem Hop Ther; 1973 Jan; 49(1):37-41. PubMed ID: 4712023
[No Abstract] [Full Text] [Related]
19. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
Kowal-Bielecka O; Distler O
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
[TBL] [Abstract][Full Text] [Related]
20. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
Sicińska J; Rudnicka L
Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
